US Patent 9777003 Tricyclic heterocycles as bet protein inhibitors
Patent 9777003 was granted and assigned to Incyte on October, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+203 characters)
Article
Patent abstract
The present invention relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Haisheng Wang0
Lixin Shao0
Stacey Shepard0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09777003 Tricyclic heterocycles as bet protein inhibitors US Patent 9777003 Tricyclic heterocycles as bet protein inhibitors
Infobox
Patent Number
09777003
Patent Number
9777003
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09777003 Tricyclic heterocycles as bet protein inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09777003
Date of patent
October 3, 2017
Patent application number
15051908
Date Filed
February 24, 2016
Patent primary examiner
Find more entities like US Patent 9777003 Tricyclic heterocycles as bet protein inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
